Exchange Traded Concepts, LLC Astrazeneca PLC Transaction History
Exchange Traded Concepts, LLC
- $4.18 Billion
- Q3 2024
A detailed history of Exchange Traded Concepts, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 24,967 shares of AZN stock, worth $1.68 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
24,967
Previous 13,652
82.88%
Holding current value
$1.68 Million
Previous $1.06 Million
82.8%
% of portfolio
0.05%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.23 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.82 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.5 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.47 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.28 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $208B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...